Press Releases Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 11:35:02 2026-02-12 am EST			Pre-market 02:49:31 am
10.84 ^EUR	-0.82%		10.88	+0.46%

Feb. 05	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading	MT
Jan. 21	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT

Press Releases

Jan. 08	Grifols appoints Laura de la Cruz as the new secretary non-member of the Board of Directors	AQ
Dec. 19	Grifols S A : receives US FDA approval for new fibrinogen concentrate, FESILTYTM (fibrinogen, human-chmt)	PU
Dec. 17	Grifols S A : Welcomes S&P Global Ratings’ Upgrade to ‘BB-’ with Stable Outlook	PU
Dec. 17	Grifols S A : Welcomes S&P Global Ratings’ Upgrade to ‘BB-’ with Stable Outlook December 17 2025	PU
Dec. 16	Grifols S A : obtains approval from the European Medicines Agency for the entire value chain of Egypt	PU
Dec. 16	Grifols S A : obtains approval from the European Medicines Agency for the entire value chain of Egypt December 16 2025	PU
Dec. 04	Grifols S A : Egypt achieves self-sufficiency in plasma-derived medicines thanks to Grifols	PU
Nov. 27	Grifols S A : appoints Tomás Dagá as Vice President of the board of Egypt (GEPD) and accelerates plasma self-sufficiency for 2026	PU
Nov. 13	Grifols S A : ’ Biotest receives first regulatory approval for its fibrinogen concentrate	PU
Nov. 12	Grifols S A : Secures 95% of Investor Support to Improve Documentation Terms of Its €1.3 Billion 7.5% Secured Notes	PU
Nov. 12	Grifols S A : Secures 95% of Investor Support to Improve Documentation Terms of Its €1.3 Billion 7.5% Secured Notes November 12 2025	PU
Nov. 12	Grifols S A : Consent Solicitation Results Announcement	PU
Nov. 11	Grifols S A : Revocation Deadline Announcement	PU
Nov. 07	Grifols S A : Welcomes Fitch Ratings’ Outlook Revision to Positive and Affirmation of 'B+' Rating	PU
Nov. 07	Grifols S A : Welcomes Fitch Ratings’ Outlook Revision to Positive and Affirmation of 'B+' Rating November 7 2025	PU
Nov. 05	Grifols S A : Conference call transcript (71fa8c6b 43e9 afc3 ba4d 858281be78a3t1762349318448)	PU
Nov. 05	Grifols S A : Conference call transcript (d46242ae d390 b6cd 2b95 5a93829ebfb7t1762326312726)	PU
Nov. 04	Grifols releases its financial information for the Q3'25	AQ
Nov. 04	Grifols S A : reports quarterly revenues of EUR 1,865 million and group profit of EUR 127 million	PU
Nov. 04	Grifols S A : reports quarterly revenues of EUR 1,865 million and group profit of EUR 127 million November 4 2025	PU
Nov. 04	Grifols S A : Presentation (fcb0eaaa 99e4 d491 c8a5 4edd382a6653t1762272202093)	PU
Nov. 04	Grifols S A : Press Release (ca977dc9 5302 47ee c6a4 7f82c3fd603ct1762272201068)	PU
Nov. 04	Grifols S A : ’ Alternative Performance Measures (63e41b80 3be2 9228 8ec7 9f8da56e38e8t1762272200287)	PU
Nov. 04	Consent Solicitation	AQ
25-10-23	Grifols S A : earns Platinum rating in EcoVadis sustainability assessment	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Grifols lifts 2025 targets but fibrinogen delay and forex drag weigh on outlook

November 06, 2025 at 05:01 am EST